A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Clinical trial NCT01597596 · TERMINATED

Trial details

NCT number: NCT01597596
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Pompe Disease (Infantile-Onset)Glycogen Storage Disease Type II (GSD II)Glycogenosis 2 Acid Maltase Deficiency

Start date: 2012-08-01
Primary completion: 2014-12-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.